Vaccine Safety Body Proposed To Remove FDA "Conflict Of Interest"
This article was originally published in The Pink Sheet Daily
Executive Summary
A proposal to move post-market vaccine safety surveillance to an independent board will be discussed by the National Vaccine Advisory Committee at its next meeting. FDA and CDC are defending the current system as enabling communication between risk management and risk assessment staff.